# Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor

> **NCT04154241** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DIAGNOSTIC_TEST:** PET/MR scan

## Key facts

- **NCT ID:** NCT04154241
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-10
- **Primary completion:** 2021-05-10
- **Final completion:** 2022-03-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04154241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04154241, "Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04154241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*